Premium
Phio Pharmaceuticals Corporation (PHIO)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipelin... Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.2099 | -42.1567944251 | 2.87 | 3 | 1.53 | 1222857 | 1.75762319 | CS |
| 4 | -0.8899 | -34.8980392157 | 2.55 | 3.108 | 1.53 | 328536 | 1.82693126 | CS |
| 12 | -1.9099 | -53.4985994398 | 3.57 | 3.88 | 1.53 | 164744 | 2.21142297 | CS |
| 26 | -4.756 | -74.126026714 | 6.4161 | 6.66 | 1.53 | 105583 | 2.68035661 | CS |
| 52 | -5.1799 | -75.7295321637 | 6.84 | 10.35 | 1.53 | 186213 | 6.03183678 | CS |
| 156 | -123.6199 | -98.6748882503 | 125.28 | 261.36 | 1.53 | 620199 | 117.55972656 | CS |
| 260 | -13.1359 | -88.7800756961 | 14.796 | 1171.8 | 1.53 | 685388 | 180.50858423 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
